Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumour escape: antitumour effectors too much of a good thing?
Graham Pawelec
Cancer Immunology Immunotherapy (2004) Vol. 53, Iss. 3, pp. 262-274
Closed Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
Paolo Serafini, Ivan Borrello, Vincenzo Bronte
Seminars in Cancer Biology (2005) Vol. 16, Iss. 1, pp. 53-65
Closed Access | Times Cited: 756
Human Tumor-Released Microvesicles Promote the Differentiation of Myeloid Cells with Transforming Growth Factor-β–Mediated Suppressive Activity on T Lymphocytes
Roberta Valenti, Veronica Huber, Paola Filipazzi, et al.
Cancer Research (2006) Vol. 66, Iss. 18, pp. 9290-9298
Open Access | Times Cited: 478
STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
Sergei Kusmartsev, Dmitry I. Gabrilovich
The Journal of Immunology (2005) Vol. 174, Iss. 8, pp. 4880-4891
Open Access | Times Cited: 438
Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators
Adit Ben‐Baruch
Seminars in Cancer Biology (2005) Vol. 16, Iss. 1, pp. 38-52
Closed Access | Times Cited: 327
Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation
Jooyoung Kim, Young‐Ok Son, Soon‐Won Park, et al.
Experimental & Molecular Medicine (2006) Vol. 38, Iss. 5, pp. 474-484
Open Access | Times Cited: 180
Increased Levels of Interleukin-10 in Serum from Patients with Hepatocellular Carcinoma Correlate with Profound Numerical Deficiencies and Immature Phenotype of Circulating Dendritic Cell Subsets
Susanne Beckebaum, Xia Zhang, Xiaohong Chen, et al.
Clinical Cancer Research (2004) Vol. 10, Iss. 21, pp. 7260-7269
Closed Access | Times Cited: 178
HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma
Liz Y. Han, Mavis S. Fletcher, Diana L. Urbauer, et al.
Clinical Cancer Research (2008) Vol. 14, Iss. 11, pp. 3372-3379
Open Access | Times Cited: 147
Revisiting the seed and soil in cancer metastasis
Martín Mendoza, Chand Khanna
The International Journal of Biochemistry & Cell Biology (2009) Vol. 41, Iss. 7, pp. 1452-1462
Open Access | Times Cited: 124
Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma
Kathleen Ebelt, Gregor Babaryka, Ainhoa M. Figel, et al.
The Prostate (2007) Vol. 68, Iss. 1, pp. 1-10
Open Access | Times Cited: 112
EZH2 Inhibition: A Promising Strategy to Prevent Cancer Immune Editing
Ning Kang, Mark Eccleston, Pier‐Luc Clermont, et al.
Epigenomics (2020) Vol. 12, Iss. 16, pp. 1457-1476
Open Access | Times Cited: 53
Involvement of IFN Regulatory Factor (IRF)-1 and IRF-2 in the Formation and Progression of Human Esophageal Cancers
Yan Wang, Dongping Liu, Ping-Ping Chen, et al.
Cancer Research (2007) Vol. 67, Iss. 6, pp. 2535-2543
Open Access | Times Cited: 95
Stress, NK cells, and cancer: Still a promissory note
Shamgar Ben‐Eliyahu, Gayle G. Page, Steven J. Schleifer
Brain Behavior and Immunity (2007) Vol. 21, Iss. 7, pp. 881-887
Closed Access | Times Cited: 87
Tumor escape mechanisms in prostate cancer
Ashley M. Miller, Pavel Pisa
Cancer Immunology Immunotherapy (2005) Vol. 56, Iss. 1, pp. 81-87
Open Access | Times Cited: 85
Challenges facing adjuvants for cancer immunotherapy
Circe Mesa, Luis E. Fernández
Immunology and Cell Biology (2004) Vol. 82, Iss. 6, pp. 644-650
Open Access | Times Cited: 82
Immune Monitoring in a Phase 1 Trial of a PSA DNA Vaccine in Patients with Hormone-Refractory Prostate Cancer
Ashley M. Miller, Volkan Özenci, Rolf Kiessling, et al.
Journal of Immunotherapy (2005) Vol. 28, Iss. 4, pp. 389-395
Closed Access | Times Cited: 73
Examination of Oral Cancer Biomarkers by Tissue Microarray Analysis
Peter Choi, C. Diana Jordan, Eduardo Méndez, et al.
Archives of Otolaryngology - Head and Neck Surgery (2008) Vol. 134, Iss. 5, pp. 539-539
Open Access | Times Cited: 63
Psychosocial factors, biological mediators, and cancer prognosis: a new look at an old story
Yori Gidron, Alain Ronson
Current Opinion in Oncology (2008) Vol. 20, Iss. 4, pp. 386-392
Closed Access | Times Cited: 62
Bacillus Calmette‐Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I‐deficient tumor cells
Rafael Carretero, Teresa Cabrera, Hernani Gil, et al.
International Journal of Cancer (2010) Vol. 129, Iss. 4, pp. 839-846
Open Access | Times Cited: 55
Molecular Profiling Predicts the Existence of Two Functionally Distinct Classes of Ovarian Cancer Stroma
Loukia N. Lili, Lilya V. Matyunina, L. DeEtte Walker, et al.
BioMed Research International (2013) Vol. 2013, pp. 1-9
Open Access | Times Cited: 52
Stroma as an Active Player in the Development of the Tumor Microenvironment
Luca Vannucci
Cancer Microenvironment (2014) Vol. 8, Iss. 3, pp. 159-166
Open Access | Times Cited: 51
Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal Cancer
Vijaykumar Holla, Dingzhi Wang, Joanne R. Brown, et al.
Journal of Biological Chemistry (2004) Vol. 280, Iss. 1, pp. 476-483
Closed Access | Times Cited: 59
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
Kazuhide Tsuji, T Hamada, Akiko Uenaka, et al.
Cancer Immunology Immunotherapy (2008) Vol. 57, Iss. 10, pp. 1429-1437
Open Access | Times Cited: 43
Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency
J H Kim, Tae Heung Kang, Kyung Hee Noh, et al.
Clinical & Experimental Immunology (2011) Vol. 165, Iss. 2, pp. 180-189
Open Access | Times Cited: 38
Tumor stroma-associated antigens for anti-cancer immunotherapy
Valeska Hofmeister, Claudia S. Vetter, David Schrama, et al.
Cancer Immunology Immunotherapy (2005) Vol. 55, Iss. 5, pp. 481-494
Open Access | Times Cited: 48
Interleukin‐10 expression significantly correlates with minor CD8+ T‐cell infiltration and high microvessel density in patients with gastric cancer
Teruhisa Sakamoto, Hiroaki Saito, Shigeru Tatebe, et al.
International Journal of Cancer (2005) Vol. 118, Iss. 8, pp. 1909-1914
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top